Literature DB >> 28293314

Clinical Spectrum of Cerebral Palsy and Associated Disability in South Egypt: A Local Survey Study.

Osama Abas1, Faten Abdelaziem2, Ayman Kilany3.   

Abstract

BACKGROUND: Cerebral palsy is the most common cause of motor disability in children with a prevalence of 2-10/1,000 live births in the developing areas. AIM: The epidemiology, clinical picture, and associated comorbidities in CP have been extensively studied in high-resource countries, but in low-resource areas, including Africa, those studies are still lacking.
METHODS: Cerebral palsy cases were prospectively recruited from every physiotherapy centre in Bani-Mazar city, Egypt, in a cross-sectional study from May 2015 to November 2015.
RESULTS: Two hundred cases were enrolled with a prevalence of 1 per 1000 live births. Within the study population, 72.5% were the spastic type, 16% were dyskinetic, 7% were ataxic, and 4.5% were hypotonic. The most common comorbidities were cognitive impairment and epilepsy affecting 77% and 38%, respectively.
CONCLUSION: Cerebral palsy in developing countries has a higher prevalence and different clinical profile regarding severity and associated disability. The perinatal and high-quality neonatal care together with physical therapy and rehabilitation programs is still lacking in developing countries.

Entities:  

Keywords:  Cerebral palsy; Egypt; comorbidity; prevalence; subtypes

Year:  2017        PMID: 28293314      PMCID: PMC5320905          DOI: 10.3889/oamjms.2017.020

Source DB:  PubMed          Journal:  Open Access Maced J Med Sci        ISSN: 1857-9655


Introduction

Cerebral palsy (CP) is a term that has been formally defined as a group of permanent disorders of the development of movement and posture, causing activity limitation, which is attributed to non-progressive disturbances that occurred in the developing fetal or infant brain. The motor disorders of cerebral palsy are often accompanied by disturbances of sensation, perception, cognition, communication and behaviour, by epilepsy and by secondary musculoskeletal problems [1]. Prevalence estimates range from 1.5-3/1,000 in western countries, with much higher and wider range, 2-10/1,000 live births, in the developing areas [2] Durkin et al. 2016. In an Egyptian study by El-Tallawy et al., 2014 [3] it was 2.04 per 1000 live births. The variation in prevalence and clinical picture depends mainly on study design, populations, and diagnostic criteria. The epidemiology, clinical picture, and associated comorbidities in CP have been extensively studied in high-resource countries, but in low-resource areas, including Africa, those studies are still lacking. CP has many risk factors. The most common are low birth weight and perinatal hypoxia accounting for almost 50% and 10-20%, respectively [4]. This study aims at identifying the prevalence and the disability profile and associated comorbidities of CP cases in a prospective cross-sectional study from referral centres of physiotherapy and rehabilitation in Bani-Mazer district, Elminia Governorate, Egypt.

Subjects and Methods

All documented CP cases, according to the consensus definition by Bax et al., 2005 [5], from Bani-Mazar city and related nearby villages have been included in this study which was conducted from May 2015 to November 2015.

Inclusion criteria

The age range was from 3 months to 18 years, with disease onset within the first year of life. Cases were recruited from every physiotherapy and rehabilitation centre.

Exclusion criteria

Cases with developmental regression, malignancy and peripheral central nervous system affection were excluded.

For evaluation

1. The Gross Motor Function Classification System (GMFCS): Is a classification system developed for children with CP. Initially, children with CP were divided into five levels by considering their independency in gross motor functions such as sitting, walking, mobilisation and transfer activities and the tools-equipment. Motor function is classified based on walking ability. Children classified as GMFCS Levels I or II were categorised as ‘walks independently’, Level III as ‘walks with handheld mobility device’, Levels IV as ‘limited walking ability’, and level V as wheel-chair bound. As motor functions of children differ according to age, functions have been defined as below 2-year old, between 2 and four years old, between 4 and six years old, between 6 and 12 years old, and above 12-year-old for each level. GMFC classification system: LEVEL I - Walks without Limitations, LEVEL II - Walks with Limitations, LEVEL III - Walks Using a Hand-Held Mobility Device, LEVEL IV - Self-Mobility with Limitations; May Use Powered Mobility, LEVEL V - Transported in a Manual Wheelchair. 2. A clinical evaluation carried out including history taking and thorough neurological examination. Associated impairments have been documented by reviewing available formal documents including the history of true recurrent seizures, cognitive assessment, visual acuity, and hearing evaluation. For hearing impairment, an official audiometry result was reviewed. A formal written consent has been taken from parents or care givers for all cases. The study was approved by the local ethical committee. Data was analysed using IBM SPSS Statistics 22.

Results

The total population under the age of 18 years old, at the area of study, was 198,776 (32%of total population). The number of CP cases in this population who receive physical therapy services was 200 representing the prevalence of 1 per 1000 live births. The demographic data of the cases (number = 200) has been presented in Table 1.
Table 1

Demographics of cases (Number = 200)

VariablesNumber%
GenderMale11055

Female9045

ResidenceRural16281

Urbane3819

Parents consanguinityPositive9648

Negative10452

Type of deliveryNormal7437

Cesarean12663

Gestational agePre-term3216

Full-term16381.5

Unknown52.5

Birth weightExtremely LBW73.5

Very LBW105

LBW3618

Normal birth weight8542.5

High birth weight136.5

Uncertain4924.5

Chronological Age3month < 2year7638

2year < 4year6030

4year < 6year3417

6year < 12year3015

LBW = low birth weight

Demographics of cases (Number = 200) LBW = low birth weight Cases with CP has been divided according to type into spastic (72.5%), dyskinetic (16%), ataxic (7%), and hypotonic (4.5%). Spastic cases have been further categorised according to the distribution of spasticity to diplegic, quadriplegic, and hemiplegic (Table 2).
Table 2

Types of CP and distribution of spasticity

Clinical variablesNumber (%)Total
Sub types of CP
Spastic145 (72.5%)200
Dyskinetic32 (16%)
Ataxic14 (7%)
Hypotonic9 (4.5%)
Distribution of spasticity
Diplegic70 (48.27%)145
Quadriplegic44 (30.3%)
Hemiplegic31 (21.4%)

CP = cerebral palsy.

Types of CP and distribution of spasticity CP = cerebral palsy. The distribution of motor impairment according to GMFCS across age groups has been presented in Table 3 and Figure 1.
Table 3

Motor impairment according to GMFCS

Level
Age rangeIIIIIIIVVTotal
0-2y61522191576
2-4y420197860
4-6y65107634
6-12y35156230
Total1945663931200

GMFCS = Gross Motor Classification System.

Figure 1

Level of impairment according to Gross Motor Functional Classification system (Birth-12 year)

Level of impairment according to Gross Motor Functional Classification system (Birth-12 year) Motor impairment according to GMFCS GMFCS = Gross Motor Classification System. Cases with hemiplegic type fall mostly in the range from level I through level III on GMFCS scale, while cases with quadriplegia are more disabled on level III through level V. There is a statistically significant difference between spastic subtypes regarding GMFCS score (Table 4).
Table 4

GMFCS according to type of spasticity

GMFCSSpasticity typeχ2
HemiplegicDiplegicQuadriplegicTotal
I105015P < 0.001
II1023437
III10241448
IV1111426
V161219
Total326944145

GMFCS = Gross Motor Classification System.

GMFCS according to type of spasticity GMFCS = Gross Motor Classification System. Associated impairment has been documented using available formal reports. Cognitive impairment was the most common as it affected 77% of cases (Table 5).
Table 5

Associated impairments

DisorderNumber (%)
Cognitive impairment145 (77%)
Epilepsy76 (38%)
Visual impairment9 (4.5 %)
Hearing impairment5 (2.5 %)
Associated impairments It has been found that both cognitive impairment and epilepsy were found in a higher percentage of children with a higher score on GMFCS (Table 6, 7).
Table 6

Distribution of cases with cognitive impairment according to GMFCS score

CognitionTotalP value
NormalAffected
GMFCSI118 (42.1%)19
II1828 (60.8%)46<0.001
III1256 (82.3%)68
IV436 (90%)40
V126 (96.2%)27
Total46154 (77%)200

GMFCS = Gross Motor Classification System.

Table 7

Distribution of cases with epilepsy according to GMFCS score

EpilepsyTotalP value
NormalAffected
GMFCSI163 (15.7%)190.01
II3412 (26%)46
III3830 (44.1%)68
IV2515 (37.5%)40
V1116 (59.2%)27
Total12476 (38%)200

GMFCS = Gross Motor Classification System.

Distribution of cases with cognitive impairment according to GMFCS score GMFCS = Gross Motor Classification System. Distribution of cases with epilepsy according to GMFCS score GMFCS = Gross Motor Classification System. Binary logistic regression models were tested for the relation between GMFCS and both cognitive impairment and epilepsy. It was founded that each grade higher on GMFCS was associated with 2.5 and 1.5 fold increased the risk for occurrence of cognitive impairment and epilepsy, respectively.

Discussion

The current study was conducted to establish a data base about children with CP receiving physical therapy services in general or health insurance hospitals as well as private centres in Bani-Mazar district Elminia governorate. There was a little higher male to female ratio (1.22), almost similar to 1.3 reported by Johnson, 2002 [6] in Europe. The urban to the rural ratio of cases was 1to 4 which is expected as the antenatal care and the medical services for neonates in general, and those with high-risk factors for CP in particular, are of low calibre and capacity. According to our sample, there were no cases above 12-year-old receiving physiotherapy service. This finding could be related to the extreme sides of the disability spectrum, being either mild and almost completely rehabilitated, or severe and neglected at home due to logistic issues (difficult transportation of grown-up patients, negative attitude towards severe cases in the low socio-economic population, or financial issues). The total number of CP cases was 200 cases, representing 1 per 1000 live birth. Prevalence of CP occurs at a rate of 2-2.5 per 1000 live births in developed countries [5]. Also in Egypt; El-Tallawy [7] reported a prevalence of 2.03and 3.6 per1000 live birth in Al-Kharga District and Al-Quseir city [3], respectively. The lower prevalence can be attributed to multiple factors. First of all, the different methodology as our study includes only those cases under the age of 18 year receiving physiotherapy services. Also, our cases are those with a disability severe enough to push the care givers to seek medical services. Second, the prevalence of CP has dynamic properties related to attitude and quality of health care and neonatal mortality [4]. According to our study, premature delivery and LBW accounted for 16% and 26.5%, respectively. These figures are low in comparison to international figures (78%) reported in developed countries. This difference is expected regarding high mortality rate of premature and LBW and a higher incidence of perinatal hypoxic events [8]. Our results on the types of CP and distribution of spasticity are similar to those reported in developing countries as reported by Kakooza-Mwesige et al. 2015 [9]. Spastic CP is the most common type, worldwide. Similarly, most of our patients (72.5%) were spastic. Dyskinetic CP (16%) is higher than the figures in western countries (6%) [10]. The higher ratio in our area can be explained by the lack of awareness of families to the impact of neonatal hyperbilirubinemia and the reluctance to seek medical advice. The ataxic cases constituted almost 7% of total number which is in consistency with local and international figures [3, 7, 9]. Spastic quadriplegic CP is the most severe form affecting 44 patients (22%) of all CP cases and (30.3%) of spastic CP patients. Epilepsy and mental sub normality were found in 38% and 77%, respectively. These figures are similar to those reported in Africa [3, 9] but higher than reported in developed areas [10]. The difference can be explained by the greater proportion of cases with extensive bilateral brain injury in diplegic and quadriplegic cases which are more vulnerable to develop symptomatic epilepsy. Also, the definition of mental sub normality in our study was based on available formal IQ test in contrast to the study by El-tallawy et al.,(2014) [3], where the IQ test was available for only 24 cases. It is worth mentioning that epilepsy was related to the level of GMFCS. This finding was also addressed by Hundozi-Hysenaj and Boshnjaku-Dallku, (2008) [11]. Regarding cognitive profile, GMFCS level was a detrimental factor which is consistent with Dalvand et al., (2012) [12], who stated that GMFCS could be considered as a gross proxy for evaluating the cognitive deficit. The gross motor function severity varied significantly across spastic subtypes (Table 4). GMFCS I through III was found to compress mainly children with diplegia whose gross and fine function is more homogeneous than in children with hemiplegia. Regarding GMFCS, 9.5% of cases were at level I, 18.5% at level IV, and 15.5% at level V. In the study conducted by Kakooza-Mwesige et al. 2015 [9], the percentage of cases at level I is very similar to little higher percentage at level IV and V. on the other hand, in a Swedish study, 32% of cases were at level I, 15% at level IV, and 16% at level V [13]. The difference mainly lies with level I which is the mildest form. This reflects the effect of public awareness, the different etiologies, the level of neonatal care, the importance of early detection, and the quality of rehabilitation programs. In conclusion, our study revealed a prevalence of 1 per 1000 live births from the age of 3 months to 18 years. Two-thirds of our study are ambulant, evidence for the paramount importance of early detection and intervention. The most common subtype is spastic CP, while the most common comorbidity is cognitive impairment followed by epilepsy. GMFCS is a useful tool for assessment, and it may offer a good predictor for epilepsy and cognitive impairment. In comparison to international figures, it seems that the perinatal and high-quality neonatal care is still lacking in developing countries. Also, being of a low-resource population, the accessibility to physical therapy and rehabilitation programs is to be revisited.
  12 in total

1.  Prevalence and characteristics of children with cerebral palsy in Europe.

Authors: 
Journal:  Dev Med Child Neurol       Date:  2002-09       Impact factor: 5.449

2.  Relationship between gross motor and intellectual function in children with cerebral palsy: a cross-sectional study.

Authors:  Hamid Dalvand; Leila Dehghan; Mohammad Reza Hadian; Awat Feizy; Seyed Ali Hosseini
Journal:  Arch Phys Med Rehabil       Date:  2012-01-21       Impact factor: 3.966

3.  Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Surveillance of Cerebral Palsy in Europe (SCPE).

Authors: 
Journal:  Dev Med Child Neurol       Date:  2000-12       Impact factor: 5.449

4.  Gross and fine motor function and accompanying impairments in cerebral palsy.

Authors:  K Himmelmann; E Beckung; G Hagberg; P Uvebrant
Journal:  Dev Med Child Neurol       Date:  2006-06       Impact factor: 5.449

5.  Epidemiology of major neurological disorders project in Al Kharga district, New Valley, Egypt.

Authors:  Hamdy N A El Tallawy; Wafaa M A Farghaly; Tarek A Rageh; Ghaydaa A Shehata; Nabil A Metwaly; Noha Abo Elftoh; Ahmed M Hegazy; Esam A El Moselhy; Ibrahim Rayan; Bastawy M A Al Fawal; Mohamed A Abd Elhamed
Journal:  Neuroepidemiology       Date:  2010-10-14       Impact factor: 3.282

Review 6.  Proposed definition and classification of cerebral palsy, April 2005.

Authors:  Martin Bax; Murray Goldstein; Peter Rosenbaum; Alan Leviton; Nigel Paneth; Bernard Dan; Bo Jacobsson; Diane Damiano
Journal:  Dev Med Child Neurol       Date:  2005-08       Impact factor: 5.449

Review 7.  Cerebral palsy.

Authors:  H Kerr Graham; Peter Rosenbaum; Nigel Paneth; Bernard Dan; Jean-Pierre Lin; Diane L Damiano; Jules G Becher; Deborah Gaebler-Spira; Allan Colver; Dinah S Reddihough; Kylie E Crompton; Richard L Lieber
Journal:  Nat Rev Dis Primers       Date:  2016-01-07       Impact factor: 52.329

8.  Pediatric Cerebral Palsy in Botswana: Etiology, Outcomes, and Comorbidities.

Authors:  David R Bearden; Baphaleng Monokwane; Esha Khurana; James Baier; Esther Baranov; Kate Westmoreland; Loeto Mazhani; Andrew P Steenhoff
Journal:  Pediatr Neurol       Date:  2016-03-17       Impact factor: 3.372

9.  Prevalence of Cerebral Palsy among 8-Year-Old Children in 2010 and Preliminary Evidence of Trends in Its Relationship to Low Birthweight.

Authors:  Maureen S Durkin; Ruth E Benedict; Deborah Christensen; Lindsay A Dubois; Robert T Fitzgerald; Russell S Kirby; Matthew J Maenner; Kim Van Naarden Braun; Martha S Wingate; Marshalyn Yeargin-Allsopp
Journal:  Paediatr Perinat Epidemiol       Date:  2016-05-23       Impact factor: 3.980

10.  Cerebral palsy in Al-Quseir City, Egypt: prevalence, subtypes, and risk factors.

Authors:  Hamdy N El-Tallawy; Wafaa Ma Farghaly; Ghaydaa A Shehata; Tarek A Rageh; Nabil A Metwally; Reda Badry; Mohamed Am Sayed; Mohamed Abd El Hamed; Ahmed Abd-Elwarth; Mahmoud R Kandil
Journal:  Neuropsychiatr Dis Treat       Date:  2014-07-08       Impact factor: 2.570

View more
  5 in total

1.  Cerebral palsy in children: subtypes, motor function and associated impairments in Addis Ababa, Ethiopia.

Authors:  Selamenesh Tsige; Ayalew Moges; Amha Mekasha; Workeabeba Abebe; Hans Forssberg
Journal:  BMC Pediatr       Date:  2021-12-03       Impact factor: 2.125

2.  Transcutaneous electrical nerve stimulation in the management of calf muscle spasticity in cerebral palsy: A pilot study.

Authors:  Delali Logosu; Thomas A Tagoe; Patrick Adjei
Journal:  IBRO Neurosci Rep       Date:  2021-10-02

3.  Evaluation of salivary parameters and Streptococcus' Mutans count in children with cerebral palsy in Egypt: a case control study.

Authors:  Sara M Quritum; Amel M Ali; May M Raouf; Tarek E I Omar; Karin M L Dowidar
Journal:  BMC Oral Health       Date:  2022-09-19       Impact factor: 3.747

Review 4.  Epidemiology of Cerebral Palsy among Children and Adolescents in Arabic-Speaking Countries: A Systematic Review and Meta-Analysis.

Authors:  Sami Mukhdari Mushta; Catherine King; Shona Goldsmith; Hayley Smithers-Sheedy; Al-Mamoon Badahdah; Harunor Rashid; Nadia Badawi; Gulam Khandaker; Sarah McIntyre
Journal:  Brain Sci       Date:  2022-06-29

5.  Towards creation of national cerebral palsy registries in Arab countries: what is missing?

Authors:  Sahar M A Hassanein; Tamer A El-Sobky
Journal:  World J Pediatr       Date:  2022-02-02       Impact factor: 2.764

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.